You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME / ABIM MOC / CE

What Happens When Patients With End-Stage Kidney Disease Forego Dialysis?

  • Authors: News Author: Mitchel L. Zoler, PhD; CME Author: Laurie Barclay, MD
  • CME / ABIM MOC / CE Released: 6/24/2022
  • Valid for credit through: 6/24/2023
Start Activity

  • Credits Available

    Physicians - maximum of 0.25 AMA PRA Category 1 Credit(s)™

    ABIM Diplomates - maximum of 0.25 ABIM MOC points

    Nurses - 0.25 ANCC Contact Hour(s) (0 contact hours are in the area of pharmacology)

    Physician Assistant - 0.25 AAPA hour(s) of Category I credit

    IPCE - 0.25 Interprofessional Continuing Education (IPCE) credit

    You Are Eligible For

    • Letter of Completion
    • ABIM MOC points

Target Audience and Goal Statement

This activity is intended for nephrologists, critical care clinicians, diabetologists/endocrinologists, family medicine and primary care clinicians, internists, nurses, pharmacists, physician assistants, and other members of the health care team for patients with end-stage kidney disease who may benefit from conservative kidney management without dialysis.

The goal of this activity is that learners will be better able to describe survival, symptom burden, and hospitalization rates in a conservative kidney management cohort managed within a structured, interprofessional Kidney Supportive Care program using shared decision making, based on a prospective observational study.

Upon completion of this activity, participants will:

  • Assess survival, symptom burden, and hospitalization rates in a conservative kidney management cohort managed within a structured, multidisciplinary Kidney Supportive Care program using shared decision making, based on a prospective observational study
  • Evaluate the clinical implications of survival, symptom burden, and hospitalization rates in a conservative kidney management cohort managed within a structured, multidisciplinary Kidney Supportive Care program using shared decision making, based on a prospective observational study
  • Outline implications for the healthcare team


Disclosures

Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Medscape policies. Others involved in the planning of this activity have no relevant financial relationships.


News Author

  • Mitchel L. Zoler, PhD

    Freelance writer, Medscape

    Disclosures

    Mitchel L. Zoler, PhD, has no relevant financial relationships.

CME Author

  • Laurie Barclay, MD

    Freelance writer and reviewer
    Medscape, LLC

    Disclosures

    Laurie Barclay, MD, has the following relevant financial relationships:
    Formerly owned stocks in: AbbVie

Editor/Compliance Reviewer

  • Yaisanet Oyola, MD

    Associate Director, Accreditation and Compliance
    Medscape, LLC

    Disclosures

    Yaisanet Oyola, MD, has no relevant financial relationships.

Nurse Planner

  • Leigh A. Schmidt, MSN, RN, CMSRN, CNE, CHCP

    Associate Director, Accreditation and Compliance
    Medscape, LLC

    Disclosures

    Leigh A. Schmidt, MSN, RN, CMSRN, CNE, CHCP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.


Accreditation Statements



In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

This activity was planned by and for the healthcare team, and learners will receive 0.25 Interprofessional Continuing Education (IPCE) credit for learning and change.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.25 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

    Contact This Provider

    For Nurses

  • Awarded 0.25 contact hour(s) of continuing nursing education for RNs and APNs; none of these credits is in the area of pharmacology.

    Contact This Provider

  • For Physician Assistants

    Medscape, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.25 AAPA Category 1 CME credits. Approval is valid until 6/24/2023. PAs should only claim credit commensurate with the extent of their participation.

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / ABIM MOC / CE

What Happens When Patients With End-Stage Kidney Disease Forego Dialysis?

Authors: News Author: Mitchel L. Zoler, PhD; CME Author: Laurie Barclay, MDFaculty and Disclosures

CME / ABIM MOC / CE Released: 6/24/2022

Valid for credit through: 6/24/2023

processing....

References

  1. National Kidney Foundation Spring Clinical Meetings: Poster 246. Presented April 6, 2022. https://cme.kidney.org/spa/courses/resource/2022-spring-clinical-meetings/event/home/posters/abstracts?abstractId=552. Accessed May 23, 2022.
  2. Chou A, Li C, Farshid S, Hoffman H, Brown M. Survival, symptoms and hospitalization of older patients with advanced chronic kidney disease managed without dialysis. Nephrol Dialysis Transpl. Published online April 19, 2022. https://academic.oup.com/ndt/advance-article-abstract/doi/10.1093/ndt/gfac154/6570719. Accessed May 23, 2022.
  3. Wong SP, Hebert PL, Laundry RJ, Hammond KW, Liu CF, Burrows NR, O'Hare AM. Decisions about renal replacement therapy in patients with advanced kidney disease in the US Department of Veterans Affairs, 2000-2011. Clin J Am Soc Nephrol. 2016;11(10):1825-1833. https://cjasn.asnjournals.org/content/11/10/1825. Accessed May 23, 2022.
  4. Wong SPY, Boyapati S, Engelberg RA, Thorsteinsdottir B, Taylor JS, O'Hare AM. Experiences of US nephrologists in the delivery of conservative care to patients with advanced kidney disease: a national qualitative study. Am J Kidney Dis. 2020;75(2):167-176. https://www.ajkd.org/article/S0272-6386(19)30909-6/fulltext. Accessed May 23, 2022.
  5. Corbett C, Moss AH. Barriers and facilitators to active medical management without dialysis. Nephrol Nurs J. 2021;48(1):69-76. https://library.annanurse.org/anna/articles/2894/view. Accessed May 23, 2022.
  6. Lam DY, Scherer JS, Brown M, Grubbs V, Schell JO. A conceptual framework of palliative care across the continuum of advanced kidney disease. Clin J Am Soc Nephrol. 2019;14(4):635-641. https://cjasn.asnjournals.org/content/14/4/635.short. Accessed May 23, 2022.
« Return to: What Happens When Patients With End-Stage Kidney Disease Forego Dialysis?
  • Print